PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2016

Intravenous infusion of mesenchymal stem cells promotes functional recovery in a model of chronic spinal cord injury.

Rat / Spinal cord injury

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 27586052 ↗2016Reported benefit

Intravenous infusion of mesenchymal stem cells promotes functional recovery in a model of chronic spinal cord injury.

RatSpinal cord injuryContusionSprague-DawleyIntravenous infusion10 weeks after injury

Model: Severe contusive spinal cord injury studied in the chronic phase

Intravenous mesenchymal stem cells given 10 weeks after severe contusion improved motor recovery, reduced blood spinal cord barrier leakage, increased microvasculature and produced extensive remyelination with increased corticospinal and serotonergic fibre sprouting.

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.